BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 36130297)

  • 1. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
    Duncavage EJ; Bagg A; Hasserjian RP; DiNardo CD; Godley LA; Iacobucci I; Jaiswal S; Malcovati L; Vannucchi AM; Patel KP; Arber DA; Arcila ME; Bejar R; Berliner N; Borowitz MJ; Branford S; Brown AL; Cargo CA; Döhner H; Falini B; Garcia-Manero G; Haferlach T; Hellström-Lindberg E; Kim AS; Klco JM; Komrokji R; Lee-Cheun Loh M; Loghavi S; Mullighan CG; Ogawa S; Orazi A; Papaemmanuil E; Reiter A; Ross DM; Savona M; Shimamura A; Skoda RC; Solé F; Stone RM; Tefferi A; Walter MJ; Wu D; Ebert BL; Cazzola M
    Blood; 2022 Nov; 140(21):2228-2247. PubMed ID: 36130297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular findings in myeloid neoplasms.
    Tran TB; Siddon AJ
    Int J Lab Hematol; 2023 Aug; 45(4):442-448. PubMed ID: 37345257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
    Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
    Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Pillai RK; Afkhami M
    Cancer Treat Res; 2021; 181():1-16. PubMed ID: 34626352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying patients with genetic predisposition to acute myeloid leukemia.
    Obrochta E; Godley LA
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
    Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
    Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics of Myeloproliferative Neoplasms.
    Zoi K; Cross NC
    J Clin Oncol; 2017 Mar; 35(9):947-954. PubMed ID: 28297629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical Validation of a 37-Gene Next-Generation Sequencing Panel for Myeloid Malignancies and Review of Initial Findings Incorporating Updated 2022 Diagnostic and Prognostic Guidelines.
    Leung B; Aung H; Nandini A; Abdulrasool G; Lau C; Seymour L
    J Mol Diagn; 2024 May; 26(5):399-412. PubMed ID: 38367765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
    Miyamoto K; Minami Y
    Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
    Kuo FC
    Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.
    Kato H; Maezawa Y; Nishijima D; Iwamoto E; Takeda J; Kanamori T; Yamaga M; Mishina T; Takeda Y; Izumi S; Hino Y; Nishi H; Ishiko J; Takeuchi M; Kaneko H; Koshizaka M; Mimura N; Kuzuya M; Sakaida E; Takemoto M; Shiraishi Y; Miyano S; Ogawa S; Iwama A; Sanada M; Yokote K
    Exp Hematol; 2022 May; 109():11-17. PubMed ID: 35240258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics of acute myeloid leukemia.
    Graubert TA; Mardis ER
    Cancer J; 2011; 17(6):487-91. PubMed ID: 22157292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decade with whole exome sequencing in haematology.
    Hansen MC; Haferlach T; Nyvold CG
    Br J Haematol; 2020 Feb; 188(3):367-382. PubMed ID: 31602633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
    Fukuhara S; Oshikawa-Kumade Y; Kogure Y; Shingaki S; Kariyazono H; Kikukawa Y; Koya J; Saito Y; Tabata M; Yoshifuji K; Mizuno K; Miyagi-Maeshima A; Matsushita H; Sugiyama M; Ogawa C; Inamoto Y; Fukuda T; Sugano M; Yamauchi N; Minami Y; Hirata M; Yoshida T; Kohno T; Kohsaka S; Mano H; Shiraishi Y; Ogawa S; Izutsu K; Kataoka K
    Cancer Sci; 2022 Aug; 113(8):2763-2777. PubMed ID: 35579198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?
    Rao AV; Smith BD
    Curr Hematol Malig Rep; 2013 Jun; 8(2):149-55. PubMed ID: 23595294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification.
    Chen X; Yuan L; Zhang Y; Wang F; Ma X; Fang J; Cao P; Liu Y; Liu Z; Liu M; Chen J; Zhou X; Liu M; Jin D; Wang T; Lu P; Liu H
    Am J Hematol; 2024 May; 99(5):824-835. PubMed ID: 38321864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications.
    Malcovati L; Ambaglio I; Elena C
    Curr Opin Oncol; 2015 Nov; 27(6):551-9. PubMed ID: 26352542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.
    McKerrell T; Moreno T; Ponstingl H; Bolli N; Dias JM; Tischler G; Colonna V; Manasse B; Bench A; Bloxham D; Herman B; Fletcher D; Park N; Quail MA; Manes N; Hodkinson C; Baxter J; Sierra J; Foukaneli T; Warren AJ; Chi J; Costeas P; Rad R; Huntly B; Grove C; Ning Z; Tyler-Smith C; Varela I; Scott M; Nomdedeu J; Mustonen V; Vassiliou GS
    Blood; 2016 Jul; 128(1):e1-9. PubMed ID: 27121471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.